1. Micetich, R. G., Abramovitch, R. A., The Chemistry of Heterocyclic Compounds, Vol. 14, Supplement Part 2, New York: Wiley, 1974.
2. Chambers, R. J., Marfat, A., Cheng, J. B. et al., Biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor-alpha, Bioorg. Med. Chem. Lett., 1997, 7: 739.
3. Boyd, E. C., Eaton, M. A. W., Warrellow, G. J., Tri-substituent phenyl derivatives as phosphodiesterase IV inhibitors and process for this preparation, PCT Int. Appl., WO94 10, 118.
4. Maini, R. N., Elliott, M. J., Brennan, F. M. et al., Benificial effects of tumor necrosis factor-alpha (TNF-α) blockade in rheumatoid arthritis (RA), Clin. Exp. Immunol., 1995, 101: 207.
5. Feldmann, M., Brennan, F. M., Eliott, M. J. et al., Tnf-alpha as a therapeutic target in rheumatoid-arthritis, Circ. Shock, 1994, 43: 179.